tradingkey.logo

Bionano Genomics Inc

BNGO
1.150USD
+0.025+2.22%
종가 02/06, 16:00ET시세는 15분 지연됩니다
11.19M시가총액
손실P/E TTM

Bionano Genomics Inc

1.150
+0.025+2.22%

자세한 내용은 Bionano Genomics Inc 회사

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Bionano Genomics Inc 정보

종목 코드 BNGO
회사 이름Bionano Genomics Inc
상장일Aug 01, 2018
CEOHolmlin (R. Erik)
직원 수98
유형Ordinary Share
회계 연도 종료Aug 01
주소9540 Towne Centre Drive
도시SAN DIEGO
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호92121
전화18588887600
웹사이트https://bionano.com/
종목 코드 BNGO
상장일Aug 01, 2018
CEOHolmlin (R. Erik)

Bionano Genomics Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-59.00%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-7.00%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-1.00%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-91.00%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Kristiina Vuori, M.D., Ph.D.
Dr. Kristiina Vuori, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alka Chaubey, Ph.D.
Dr. Alka Chaubey, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-59.00%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-7.00%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-1.00%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-91.00%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
사업별USD
이름
수익
비율
Consumables
3.77M
51.21%
Instruments
1.62M
21.98%
Software
1.54M
20.93%
Services and other
433.00K
5.88%
지역별USD
이름
수익
비율
EMEIA
3.63M
49.30%
Americas
2.85M
38.62%
Asia Pacific
890.00K
12.08%
사업별
지역별
사업별USD
이름
수익
비율
Consumables
3.77M
51.21%
Instruments
1.62M
21.98%
Software
1.54M
20.93%
Services and other
433.00K
5.88%

주식 보유 통계

마지막 업데이트: Sat, Feb 7
마지막 업데이트: Sat, Feb 7
주주
주주 유형
주주
주주
비율
Lincoln Alternative Strategies LLC
5.16%
Heights Capital Management, Inc.
4.67%
GSA Capital Partners LLP
3.32%
Abbe (Richard)
3.17%
Iroquois Capital Management, LLC
1.91%
기타
81.77%
주주
주주
비율
Lincoln Alternative Strategies LLC
5.16%
Heights Capital Management, Inc.
4.67%
GSA Capital Partners LLP
3.32%
Abbe (Richard)
3.17%
Iroquois Capital Management, LLC
1.91%
기타
81.77%
주주 유형
주주
비율
Investment Advisor
6.35%
Hedge Fund
5.39%
Corporation
5.16%
Individual Investor
3.19%
Investment Advisor/Hedge Fund
0.37%
Research Firm
0.10%
기타
79.44%

기관 주식 보유

마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
123
914.11K
2.31%
--
2025Q3
133
914.11K
2.58%
+813.59K
2025Q2
185
100.52K
13.17%
-3.70K
2025Q1
250
104.22K
14.32%
-326.48K
2024Q4
274
101.50K
13.43%
+9.88K
2024Q3
289
91.66K
15.30%
-74.07K
2024Q2
302
110.36K
23.52%
-110.43K
2024Q1
309
82.51K
16.21%
-65.29K
2023Q4
315
103.94K
16.84%
+13.56K
2023Q3
336
90.39K
20.40%
+284.00
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Lincoln Alternative Strategies LLC
525.00K
5.16%
+525.00K
--
Sep 17, 2025
Heights Capital Management, Inc.
475.00K
4.67%
+475.00K
--
Sep 16, 2025
Abbe (Richard)
322.53K
3.17%
+322.53K
--
Sep 30, 2025
Iroquois Capital Management, LLC
194.66K
1.91%
+194.66K
--
Sep 30, 2025
The Vanguard Group, Inc.
50.46K
0.5%
+50.46K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
26.84K
0.26%
+7.97K
+42.22%
Sep 30, 2025
Carret Asset Management, LLC
25.00K
0.25%
+25.00K
--
Sep 30, 2025
HRT Financial LP
20.33K
0.2%
+20.33K
--
Sep 30, 2025
Two Sigma Investments, LP
15.58K
0.15%
+15.58K
--
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
비율0%
Avantis US Small Cap Equity ETF
비율0%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
날짜
배당락일
유형
비율
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
KeyAI